14 results
424B5
IPA
ImmunoPrecise Antibodies Ltd
23 Feb 24
Prospectus supplement for primary offering
5:26pm
and other requirements compared to those that are otherwise applicable generally to public companies, including: reduced executive compensation disclosure … , exemptions from the requirement to hold non-binding advisory votes on executive compensation and an exemption from the auditor attestation
424B5
IPA
ImmunoPrecise Antibodies Ltd
7 Dec 23
Prospectus supplement for primary offering
4:53pm
to those that are otherwise applicable generally to public companies, including: reduced executive compensation disclosure, exemptions from … the requirement to hold non-binding advisory votes on executive compensation and an exemption from the auditor attestation requirements under Section 404
424B5
IPA
ImmunoPrecise Antibodies Ltd
5 Dec 23
Prospectus supplement for primary offering
4:02pm
executive compensation disclosure, exemptions from the requirement to hold non-binding advisory votes on executive compensation and an exemption from
6-K
EX-99.1
IPA
ImmunoPrecise Antibodies Ltd
20 Oct 23
Current report (foreign)
2:56pm
to be considered important to a reasonable investor making an investment decision.
STATEMENT OF EXECUTIVE COMPENSATION
General
The following information … January 11, 2019 until August 5, 2022.
Compensation Discussion and Analysis
Compensation Philosophy and Objectives
The Company's executive compensation program
6-K
EX-99.1
IPA
ImmunoPrecise Antibodies Ltd
18 Sep 23
Statement of Executive Compensation
2:47pm
OF EXECUTIVE COMPENSATION
(for the financial year ended April 30, 2023)
This Statement of Executive Compensation is filed by ImmunoPrecise Antibodies Ltd … monetary amounts herein are expressed in Canadian Dollars ("$") unless otherwise stated.
For the purpose of this Statement of Executive Compensation: "NEO
6-K
bmeqfogay2er hlqs71
18 Sep 23
Statement of Executive Compensation
2:47pm
424B5
43be8r1e zf79pf
15 Aug 23
Prospectus supplement for primary offering
5:47pm
6-K
EX-99.2
a5myigr63
17 Nov 22
Current report (foreign)
9:36am
6-K
EX-99.1
ad9ug8b4jj3qgdg
1 Nov 22
Current report (foreign)
7:07pm
6-K
tlvql
1 Nov 22
Current report (foreign)
7:07pm
6-K
EX-99.2
5wcnjxaq4pm s6aytw
14 Apr 22
Current report (foreign)
10:18am
6-K
EX-99.1
xyua6a
12 Nov 21
Current report (foreign)
8:58am
F-10
EX-4.6
nz287o5yvpa1m
9 Nov 20
Registration of securities (Canada)
8:18am
40FR12B/A
EX-99.108
0k5jy7z fvvp4u
4 Nov 20
Initial registration of securities (Canada) (amended)
4:05pm
- Prev
- 1
- Next